Neuro-joy

Wearable Neurostimulation Treatment for Anxiety Disorders

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in October 2023 by Nabila Farah, Neuro-joy operates with 1–10 employees. The company is currently in the Pre-Funding stage, developing a neurostimulation technology for anxiety disorders.

Business overview

Neuro-joy is a Health Tech & Life Sciences company focused on developing a disruptive neurostimulation technology for the treatment of anxiety disorders and stress. The company's core product is a drug-free, easy-to-use, and cost-effective wearable device accompanied by an app, designed for individuals who may not typically seek professional help. Neuro-joy operates within the Digital Healthcare and Digital Therapeutics sectors, targeting patients in the broader Healthcare & Life Sciences market.

Company Intelligence Q&A

What is Neuro-joy's primary focus?
Neuro-joy is developing a disruptive neurostimulation technology aimed at treating anxiety disorders and stress.
When was Neuro-joy founded?
Neuro-joy was founded in October 2023.
Who is the founder of Neuro-joy?
Nabila Farah is the founder of Neuro-joy.
What is the current product development stage for Neuro-joy?
Neuro-joy's product is currently in the Clinical Trial stage, indicating it is undergoing testing to assess its safety and efficacy before broader market release.
What market does Neuro-joy target?
Neuro-joy targets patients within the Healthcare & Life Sciences sector with its B2C business model.